Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner

Hypertension

Volumn 53, Issue 4, 2009, Pages 661-667

  Torrens, Christopher ^a   Kelsall, Christopher J ^a   Hopkins, Laura A ^a   Anthony, Frederick W ^a   Curzen, Nick P ^a,b   Hanson, Mark A ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Endothelium; Experimental models; Fetal programming; Inflammation; Nitric oxide; Statins (atorvastatin); Vascular biology

Indexed keywords

ATORVASTATIN; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; DRINKING WATER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; MARKER; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CARBON DIOXIDE BREATHING; CELL FUNCTION; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; INFLAMMATION; MALE; MESENTERIC ARTERY; MOLECULAR BIOLOGY; MYOGRAPHY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN RESTRICTION; RAT; THORACIC AORTA; VASODILATATION; WEANING; WISTAR RAT;

ANIMALS; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; MALE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN-ENERGY MALNUTRITION; PYRROLES; RATS; RATS, WISTAR; RNA, MESSENGER; VASCULITIS; VASOCONSTRICTION; WEIGHT GAIN;

EID: 64849116250     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.122820     Document Type: Article

References (45)

1. McMillen 1C, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005; 85:571-633.
2. Langley SC, Jackson AA. Increased systolic blood pressure in adult rats induced by fet al. exposure to maternal low protein diets. Clin Sci (Lond). 1994;86:217-222.
3. Brawley L, Itoh S, Torrens C, Barker A, Bertram C, Poston L, Hanson M. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res. 2003, 54:83-90.
4. Torrens C, Brawley L, Anthony FW, Dance CS, Dunn R, Jackson AA, Poston L, Hanson MA. Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension. 2006;47:982-987.
5. Lamireau D, Nuyt AM, Hou X, Bemier S, Beauchamp M, Gobeil F Jr, Lahaie I, Varma DR, Chemtob S. Altered vascular function in fet al. programming of hypertension. Stroke. 2002;33:2992-2998.
6. Busse R, Fleming I. Vascular endothelium and blood flow. Handb Exp Pharmacol. 2006;43-78.
7. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Piccoli A, Valentini U, Cimino A, Girelli A, Salvetti M, De Ciuceis C, Tiberio GA, Giulini SM, Sleiman I, Monteduro C, Rosei EA. Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus. J Hypertens. 2001;19:913-919.
8. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol. 2001;38 (suppl 2) : S11-S14.
9. Landmesser U, Homig B, Drexler H Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109:II27-II33.
10. Delles C, Miller WH, Dominiczak AF. Targeting reactive oxygen species in hypertension. Antioxid Redox Signal. 2008;10:106I-1077.
11. Lavi S, Yang EH, Prasad A, Mathew V, Bareness GW, Rihal CS, Lerman LO, Lerman A. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension. 2008;51:127-133.
12. Gelosa P, Cimino M, Pignieri A, Tremoli E, Guerrini U, Sironi L. The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manag. 2007;3:567-577.
13. Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng XY, Zhang F, Beck KR, Olin JW, Fung ET, Cooke JP. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation. 2007;1 16:1396-1403.
14. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vase Biol. 2001; 21:1712-1719.
15. Laufs U, La F, V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97: 1129-1135.
16. Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, Nishi H, Inoue N, Yokoyama M. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 2001;154: 87-96.
17. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004; 109:11139-11143.
18. Torrens C. Brawley L, Barker AC, Itoh S, Poston L, Hanson MA. Maternal protein restriction in the rat impairs resistance artery but not conduit artery function in pregnant offspring. J Physiol. 2003;547: 77-84.
19. Minamiyama Y, Takemura S, Yamasaki K, Hai S, Hirohashi K, Funae Y, Okada S. Continuous administration of organic nitrate decreases hepatic cytochrome P450. J Pharmacol Exp Ther. 2004;308: 729-735.
20. Langley-Evans SC, Sculley DV. Programming of hepatic antioxidant capacity and oxidative injury in the ageing rat. Mech Ageing Dev. 2005; 126:804-812.
21. Ness GC, Chambers CM, Lopez D. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity. J Lipid Res. 1998;39:75-84.
22. Khan IY, Taylor PD, Dekou V, Seed PT, Lakasing L, Graham D, Dominiczak AF, Hanson MA, Poston L. Gender-linked hypertension in offspring of lard-fed pregnant rats. Hypertension. 2003;41:168-175.
23. Franco MC, Fortes ZB, Akamine EH, Kawamoto EM, Scavone C, de Britto LR, Muscara MN, Teixeira SA, Tostes RC, Carvalho MH, Nigro D. Tetrahydrobiopterin improves endothelial dysfunction and vascular oxidative stress in microvessels of intrauterine undernourished rats. J Physiol. 2004;558:239-248.
24. Torrens C, Hanson MA, Gluckman PD, Vickers MH. Maternal undernutrition leads to endothelial dysfunction in adult male rat offspring independent of postnatal diet. Br J Nutr. 2009;101:27-33.
25. Waldron GJ, Ding H, Lovren F, Kubes P, Triggle CR. Acetylcholineinduced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br J Pharmacol. 1999;128:653-658.
26. Rodford JL, Torrens C, Siow RC, Mann GE, Hanson MA, Clough GF. Endothelial dysfunction and reduced antioxidant protection in an animal model of the developmental origins of cardiovascular disease. J Physiol. 2008;586:4709-4720.
27. Casanello P, Sobrevia L. Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res. 2002;91: 127-134.
28. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age-related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:274-279.
29. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003; 111:1201-1209.
30. Winterbourn CC, Chan T, Buss IH, Inder TE, Mogridge N, Darlow BA. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res. 2000;48: 84-90.
31. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res. 2002;91:938-944.
32. Didion SP, Kinzenbaw DA, Schrader LI, Faraci FM. Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension. 2006;48:1072-1079.
33. Paraskevas KI, Mikhailidis DP. C-reactive protein (CRP) : more than just an innocent bystander? Curr Med Res Opin. 2008;24:75-78."
34. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340:115-126.
35. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol. 2007;43:780-791.
36. Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, Szalai AJ, Ward ME, Verma S. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis. 2008;201:318-325.
37. Castro PF, Miranda R, Verdejo HE, Greig D, Gabrielli LA, Alcaino H, Chiong M, Bustos C, Garcia L, Mellado R, Vukasovic JL, Godoy I, Lavandero S. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity. J Heart Lung Transplant. 2008;27:435-441.
38. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.
39. Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol. 2008; 158:203-207.
40. Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res. 1993;30:73-79.
41. Cleal JK, Poore KR, Boullin JP, Khan O, Chau R, Hambidge O, Torrens C, Newman JP, Poston L, Noakes DE, Hanson MA, Green LR. Mismatched pre- and postnatal nutrition leads to cardiovascular dysfunction and altered renal function in adulthood. Proc Natl Acad Sci USA. 2007; 104:9529-9533.
42. Ghanam K, Javellaud J, Ea-Kim L, Oudart N. The protective effect of 17 beta-estradiol on vasomotor responses of aorta from cholesterol-fed rabbit is reduced by inhibitors of superoxide dismutase and catalase. Biochem Biophys Res Commun. 1998;249:858-864.
43. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N EnglJ Med. 1999;340:1801-1811.
44. Wagner AH, Schroeter MR, Hecker M. 17beta-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J. 2001; 15:2121-2130.
45. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997; 95:252-264.